Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children

Completed · Phase 2

Conditions studied: Asthma

In brief

To determine the effect of medical food on reducing asthma symptoms in asthmatic children.

Key facts

Study ID

NCT01087710

Run by

Abbott Nutrition

People needed

43

Starts

2004-07-01

Expected to finish

2006-01-01

Last updated by the study team

2010-03-16

Who can join

Age: 6 and older, up to 14. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female children who have had mild to moderate persistent asthma for at least 1 year and are between 6 and 14 years of age, and not currently being treated with steroids are eligible.
• Each subject also has to have:
• Subject is off of controller therapy 4 wks preceding visit 1.
• Mild to moderate persistent asthma
• Methacholine responsiveness with an FEV1 PC20
• Able to perform reproducible spirometry
• Verbal assent in addition to consent
• History of prior clinical varicella or varicella vaccine.
• Nonsmoker in past year.

You may not qualify if…

• Asthma symptoms and/or albuterol use consistent with severe persistent asthma during the run-in period.
• Subject with FEV1 < 80% predicted at visit 1 or FEV1 < 70% predicted at visit 2.
• Two or more hospitalizations for asthma in the past year.
• Subject has received oral, nasal, inhaled, or IM corticosteroids during the preceding month.
• Subject has received leukotriene modifiers, theophylline derivatives, or mast cell stabilizers for asthma within 4 weeks before visit 1
• Subject is receiving one or more of the following medications:
• Astemizole prior to 3 months of visit 1
• Oral, inhaled or parenteral corticosteroids prior to 4 weeks of visit 1
• Cromolyn, antimuscarinics, cimetidine, metoclopramide, phenobarbital, phenytion, terfenadine, loratadine, or anticholingeric agents prior to 2 weeks of visit 1.
• Theophylline prior to 4 weeks of visit 1
• Subject with active upper respiratory tract infection prior to 4 weeks before visit 1
• Subject with acute sinus disease requiring antibiotic treatment within 1 week before visit
• Subject with an emergency department treatment for asthma within 1 month, prior intubation for asthma, or hospitalization for asthma within 3 months
• Subject has known bleeding disorder and/or is on medication known to have significant anticoagulant effects.
• Subject has known hypersensitivity to any of the ingredients
• Subject is taking either pill, powder, or liquid forms of nutritional and/or health food supplements within the past 4 weeks prior to visit
• Subject unable to tolerate or unwilling to take the full dose of the nutritional study formulas
• Cystic fibrosis or any other chronic lung disease other than asthma.
• Subject having gastroesophogeal reflux undergoing medical treatment
• Significant medical illness other than asthma that could require oral corticosteroids during the study.
• Subject is receiving allergen hyposensitization therapy other than an established maintenance regimen
• Subject has received IV globulins or immunosuppressants.
• Subject is known to be human immunodeficiency virus (HIV) positive.
• Pregnancy or lactation.
• If of child bearing potential, failure to practice abstinence or use of an acceptable birth control method.

Where it is running

• National Jewish Health — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.